| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5616929 | The Journal of Thoracic and Cardiovascular Surgery | 2017 | 38 Pages |
Abstract
Invasive mediastinal staging in NSCLC is unlikely to be cost-effective in clinical N0 patients if pN2 <2.5%. In patients with probability of mediastinal metastasis between 2.5% and 57% EBUS-TBNA is cost-effective as the only staging modality. Confirmatory mediastinoscopy should be considered in high-risk patients (pN2Â >Â 57%) in case of negative EBUS-TBNA.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katarzyna MD, FRCPC, MPH, Ursula MD, MSc, Uwe MD, MSc, MPH, Eshetu MSc, PStat, Gail MD, Thomas Kenneth MD, MSc, PhD, Andrew MD, MSc, Marc MD, MSc, Marcelo MD, MSc, Shaf MD, MSc, Kazuhiro MD, PhD,